A carregar...

Immune checkpoint inhibitor—related dermatologic adverse events

Immune checkpoint inhibitors have emerged as a pillar in the management of advanced malignancies. However, nonspecific immune activation may lead to immune-related adverse events, wherein the skin and its appendages are the most frequent targets. Cutaneous immune-related adverse events include a div...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Acad Dermatol
Main Authors: Geisler, Amaris N., Phillips, Gregory S., Barrios, Dulce M., Wu, Jennifer, Leung, Donald Y. M., Moy, Andrea P., Kern, Jeffrey A., Lacouture, Mario E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7572894/
https://ncbi.nlm.nih.gov/pubmed/32454097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2020.03.132
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!